NPS Pharmaceuticals, Inc. (NPSP) To Webcast Investor And Analyst Event
12/5/2013 8:47:41 AM
More...
|
NPS Pharmaceuticals, Inc. (NPSP) to Present at Deutsche Bank (DB) BioFEST Conference
11/26/2013 6:43:12 AM
More...
|
NPS Pharmaceuticals, Inc. (NPSP) Named One Of New Jersey’s 50 Fastest Growing Companies By NJBIZ
11/20/2013 9:37:51 AM
More...
|
NPS Pharmaceuticals, Inc. (NPSP)’ President And CEO Dr. Francois Nader Receives Ernst & Young LLP National Entrepreneur Of The Year® 2013 Award In The Life Sciences Category
11/18/2013 10:09:30 AM
More...
|
Francois Nader, MD, President And CEO Of NPS Pharmaceuticals, Inc. (NPSP), named EY Entrepreneur Of The Year™ 2013 National Life Sciences Award Winner
11/18/2013 8:08:41 AM
More...
|
NPS Pharmaceuticals, Inc. (NPSP) Announces FDA Acceptance of Supplemental New Drug Application For Gattex® (Teduglutide [rDNA Origin]) For Injection
11/13/2013 9:27:03 AM
More...
|
NPS Pharmaceuticals, Inc. (NPSP) To Present At Jefferies and Co. Global Healthcare Conference
11/12/2013 10:15:16 AM
More...
|
NPS Pharmaceuticals, Inc. (NPSP) Reports Third Quarter 2013 Financial Results and Provides Business Update
11/6/2013 9:22:47 AM
More...
|
NPS Pharmaceuticals, Inc. (NPSP) to Report Third Quarter 2013 Financial Results
10/29/2013 6:35:36 AM
More...
|
NPS Pharmaceuticals, Inc. (NPSP) Submits Biologic License Application to the FDA for Natpara® in Hypoparathyroidism
10/25/2013 9:51:16 AM
More...
|
|